ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Total liabilities 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) total liabilities at each fiscal year-end, per SEC filings.
$919.2MFY2025 · since FY2016: $32.6M → $919.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $919.2M | -3.7% |
| FY2024 | $954.4M | +93.1% |
| FY2023 | $494.2M | +68.4% |
| FY2022 | $293.4M | -2.6% |
| FY2021 | $301.3M | +396.2% |
| FY2020 | $60.7M | -42.3% |
| FY2019 | $105.3M | +565.6% |
| FY2018 | $15.8M | -30.0% |
| FY2017 | $22.6M | -30.7% |
| FY2016 | $32.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice